This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The prevalence of hyperhidrosis is reported to be around 1%. This figure is thought to be much higher since the majority of cases are not reported to primary care (1).

  • according to a large American national survey, only 38% of patients with a primary pattern of symptoms had consulted a health professional
  • it is estimated that there is a 15 year delay in presentation of patients with hyperhidrosis to primary care

The disease is seen in equal ratios among the sexes and may be seen at any age:

  • the mean age of onset was 14 years old
  • in teenagers, the estimated prevalence is 1.6%
  • children tend to present with palmoplantar hyperhidrosis
  • axillary hyperhidrosis (linked to the development of sweat glands) is commonly seen after the onset of puberty

In 30% to 50% of cases of primary hyperhydrosis, a family history is reported (2).

Reference:

  1. Benson RA, Palin R, Holt PJ, Loftus IM. Diagnosis and management of hyperhidrosis. BMJ. 2013;347:6800
  2. Ashton S et al. Hyperhidrosis: assessment and management in general practice. British Journal of General Practice 2024; 74 (742): 236-238. DOI: 10.3399/bjgp24X737361

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.